Neurocrine Biosciences Inc

Skandinaviska Enskilda Banken AB (publ) NBIX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

58,503

Value ($000)

8,298

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	8,298	0.0%	58,503	12/31/2025
2025 Q3	11/7/2025	8,576	0.0%	61,118	9/30/2025
2025 Q2	8/13/2025	9,096	0.0%	72,390	6/30/2025
2025 Q1	5/7/2025	15,779	0.1%	142,761	3/31/2025
2024 Q4	2/10/2025	24,728	0.1%	180,406	12/31/2024
2024 Q3	11/7/2024	34,993	0.2%	303,842	9/30/2024
2024 Q2	8/13/2024	16,497	0.1%	119,837	6/30/2024
2024 Q1	5/13/2024	16,131	0.1%	116,960	3/31/2024
2023 Q4	2/14/2024	8,241	0.0%	62,541	12/31/2023
2023 Q3	11/9/2023	4,498	0.0%	39,982	9/30/2023
2023 Q2	8/7/2023	11,912	0.1%	126,317	6/30/2023
2023 Q1	5/11/2023	18,695	0.1%	184,695	3/31/2023
2022 Q4	2/8/2023	18,528	0.1%	155,121	12/31/2022
2022 Q3	11/14/2022	16,652	0.1%	156,784	9/30/2022
2022 Q2	8/10/2022	14,871	0.1%	152,551	6/30/2022
2022 Q1	5/11/2022	14,555	0.1%	155,253	3/31/2022
2021 Q4	2/10/2022	13,001	0.1%	153,620	12/31/2021
2021 Q3	11/10/2021	14,745	0.1%	153,734	9/30/2021
2021 Q2	8/10/2021	14,998	0.1%	154,114	6/30/2021
2021 Q1	5/14/2021	13,375	0.1%	137,529	3/31/2021
2020 Q4	2/11/2021	5,350	0.0%	55,814	12/31/2020
2020 Q3	11/12/2020	5,401	0.0%	56,170	9/30/2020
2020 Q2	8/13/2020	5,539	0.0%	45,400	6/30/2020
2020 Q1	5/13/2020	3,410	0.0%	39,400	3/31/2020
2019 Q4	2/14/2020	5,729	0.0%	53,300	12/31/2019